Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing NaN - NaN of 110
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in United States (IGM-2644)

Recruiting
  • Multiple Myeloma
  • Duarte, California
  • +4 more
Jun 9, 2023

Multiple Myeloma Trial in Worldwide (Iberdomide, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Orange, California
  • +270 more
Apr 11, 2023

Multiple Myeloma Trial in Spain, United States (BB2121, CC-220, BMS-986405)

Recruiting
  • Multiple Myeloma
  • BB2121
  • +2 more
  • Birmingham, Alabama
  • +33 more
Jan 26, 2023

Multiple Myeloma Trial in Worldwide (Selinexor, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Birmingham, Alabama
  • +60 more
Jan 24, 2023

Multiple Myeloma Trial in Worldwide (Cevostamab, Tocilizumab)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +17 more
Jan 23, 2023

Multiple Myeloma, Non-Hodgkin Lymphoma, B-Cell Lymphoma Trial in Korea, Republic of, United States (Tiragolumab,

Active, not recruiting
  • Multiple Myeloma
  • +2 more
  • Denver, Colorado
  • +12 more
Jan 19, 2023

Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +26 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +198 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab IV, Lenalidomide, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Daratumumab IV
  • +3 more
  • Birmingham, Alabama
  • +211 more
Jan 17, 2023

Multiple Myeloma, Myeloma, Myeloma Multiple Trial in United States (KTX-1001)

Recruiting
  • Multiple Myeloma
  • +2 more
  • Scottsdale, Arizona
  • +5 more
Jan 12, 2023

Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Duarte, California
  • +9 more
Jan 11, 2023

Multiple Myeloma Trial in Worldwide (Modakafusp alfa, Lenalidomide, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Modakafusp alfa
  • +5 more
  • Little Rock, Arkansas
  • +53 more
Jan 12, 2023

Multiple Myeloma Trial in United States (Isatuximab, Carfilzomib, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Isatuximab
  • +2 more
  • San Francisco, California
  • +3 more
Dec 24, 2022

Multiple Myeloma Trial in Worldwide (bb2121, Daratumumab, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • +8 more
  • Birmingham, Alabama
  • +59 more
Dec 13, 2022

MDS, Multiple Myeloma, Anemia Trial in France, Italy, United States (INCB000928)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Palo Alto, California
  • +13 more
Dec 12, 2022

Multiple Myeloma, Lymphoma, Non-Hodgkin's Trial in United States (CFT7455, Dexamethasone Oral)

Recruiting
  • Multiple Myeloma
  • Lymphoma, Non-Hodgkin's
  • Phoenix, Arizona
  • +12 more
Dec 12, 2022

Multiple Myeloma, DLBCL, Glioblastoma Multiforme Trial in Worldwide (CC-223)

Completed
Has Results
  • Multiple Myeloma
  • +6 more
  • Los Angeles, California
  • +15 more
Dec 9, 2022

Multiple Myeloma Trial in Worldwide (Pomalidomide, Bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Mobile, Alabama
  • +278 more
Dec 6, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • New Port Richey, Florida
  • +94 more
Nov 30, 2022

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Birmingham, Alabama
  • +125 more
Nov 21, 2022

Validation for Early Cancer Detection and Minimal Residual

Recruiting
  • Brain Cancer
  • +19 more
    • Duarte, California
    • +6 more
    Nov 10, 2022

    Multiple Myeloma Trial in United States (CC-95266, Fludarabine, Cyclophosphamide)

    Recruiting
    • Multiple Myeloma
    • Birmingham, Alabama
    • +19 more
    Oct 11, 2022

    Multiple Myeloma Trial in Japan, United States (JNJ-68284528)

    Completed
    • Multiple Myeloma
    • JNJ-68284528
    • Phoenix, Arizona
    • +20 more
    Oct 5, 2022

    Multiple Myeloma Trial in Nashville (Cevostamab, Tocilizumab)

    Recruiting
    • Multiple Myeloma
    • Nashville, Tennessee
      Tennessee Onc., PLLC - SCRI
    Sep 8, 2022

    Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Pleiotropic Pathway Modifier Trial in Worldwide (CC-122)

    Active, not recruiting
    • Multiple Myeloma
    • +5 more
    • Duarte, California
    • +38 more
    Aug 18, 2022